Algert Global’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-137,390
Closed -$372K 1227
2025
Q4
$372K Buy
137,390
+34,980
+34% +$115K 0.01% 983
2025
Q3
$433K Sell
102,410
-129,360
-56% -$569K 0.01% 941
2025
Q2
$1.15M Sell
231,770
-45,880
-17% -$199K 0.02% 777
2025
Q1
$1.22M Buy
+277,650
New +$1.3M 0.03% 728
2024
Q3
Sell
-181,251
Closed -$1.41M 1330
2024
Q2
$1.41M Buy
181,251
+16,456
+10% +$122K 0.05% 574
2024
Q1
$1.17M Sell
164,795
-20,351
-11% -$135K 0.05% 576
2023
Q4
$1.24M Sell
185,146
-54,591
-23% -$307K 0.05% 562
2023
Q3
$1.35M Sell
239,737
-228,420
-49% -$1.52M 0.06% 496
2023
Q2
$2.58M Sell
468,157
-152,060
-25% -$818K 0.11% 303
2023
Q1
$3.88M Buy
620,217
+560,807
+944% +$3.13M 0.18% 154
2022
Q4
$277K Buy
59,410
+31,890
+116% +$157K 0.02% 944
2022
Q3
$129K Sell
27,520
-46,935
-63% -$296K 0.01% 1085
2022
Q2
$441K Buy
+74,455
New +$829K 0.03% 799
2022
Q1
Sell
-19,175
Closed -$627K 1224
2021
Q4
$627K Buy
+19,175
New +$771K 0.08% 453

Other funds holding GDRX

Algert Global's GDRX Position: Q1 2026 in Review

Algert Global sold out of GoodRx Holdings (GDRX) in Q1 2026, closing a stake of 137,390 shares — an estimated $372K sold.

Algert Global first reported a position in GDRX in Q4 2021 and held it in 14 quarters. The position peaked at $3.88M in Q1 2023. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Algert Global reported no remaining GoodRx Holdings position as of Q1 2026 after selling out during the quarter.
  • Algert Global sold 137,390 GoodRx Holdings shares in Q1 2026, an estimated $372K.
  • Algert Global first reported a position in GoodRx Holdings in Q4 2021 and held it in 14 quarters.
  • Algert Global's GoodRx Holdings position peaked at $3.88M in Q1 2023.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.